Senescence-Related lncRNA Signature Predicts Prognosis, Response to Immunotherapy and Chemotherapy in Skin Cutaneous Melanoma.

Lin, Kefan; Zhou, Yingtong; Lin, Yanling; Feng, Yuanyuan; Chen, Yuting; Cai, Longmei

Lin, Kefan; Zhou, Yingtong; Lin, Yanling; Feng, Yuanyuan; Chen, Yuting; Cai, Longmei.

Afiliação

Lin K; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Zhou Y; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Lin Y; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Feng Y; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Chen Y; First Clinical Medical College, Southern Medical University, Guangzhou 510515, China.
Cai L; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.

Biomolecules ; 13(4)2023 04 09.

Article em En | MEDLINE | ID: mdl-37189408

Assuntos

Melanoma; RNA Longo não Codificante; Neoplasias Cutâneas; Humanos; Melanoma/tratamento farmacológico; Melanoma/genética; Neoplasias Cutâneas/tratamento farmacológico; Neoplasias Cutâneas/genética; RNA Longo não Codificante/genética; Imunoterapia; Microambiente Tumoral/genética; Melanoma Maligno Cutâneo

Palavras-chave

chemotherapy drugs; immunotherapy; lncRNA; melanoma; prognostic signature; senescence; tumor burden mutation; tumor immune microenvironment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / RNA Longo não Codificante / Melanoma Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Biomolecules Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google